EcoDrugPlus

Ensembl ID : ENSACLG00000016488
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSACLG00000022767
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSACLG00000023267
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSACLG00000015489
Gene Symbol: PARP1
1 Cross references
209 Possible Orthologues:

Ensembl ID : ENSACLG00000008645
Gene Symbol: RPS21
1 Cross references
301 Possible Orthologues:

Ensembl ID : ENSACLG00000004813
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSACLG00000022759
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSACLG00000021708
Gene Symbol: PLK4
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSACLG00000024950
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSACLG00000022424
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSACLG00000000286
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSACLG00000015423
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).